[Treatment of chronic hepatitis C in patients with HIV-coinfection].
Sauleda
S
S
Servicio de Hepatología-Medicina Interna. Hospital Universitario Vall d'Hebron. Barcelona. Spain.
Juárez
A
A
Esteban
J I
JI
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D000998:Antiviral Agents / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D018450:Disease Progression; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons